| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans
|
Ye, Yihua E.
|
|
2017
|
79 |
3 |
p. 507-518
|
artikel
|
| 2 |
Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia
|
Nishikawa, Yoshitaka
|
|
2017
|
79 |
3 |
p. 629-633
|
artikel
|
| 3 |
An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitor
|
Titze, Melanie I.
|
|
2017
|
79 |
3 |
p. 545-558
|
artikel
|
| 4 |
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
|
Clarke, Jennifer L.
|
|
2017
|
79 |
3 |
p. 603-610
|
artikel
|
| 5 |
Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives
|
Bhaw-Luximon, Archana
|
|
2017
|
79 |
3 |
p. 451-466
|
artikel
|
| 6 |
Asparaginase pharmacology: challenges still to be faced
|
Lanvers-Kaminsky, Claudia
|
|
2017
|
79 |
3 |
p. 439-450
|
artikel
|
| 7 |
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting
|
Pergolizzi, Joseph V.
|
|
2017
|
79 |
3 |
p. 467-477
|
artikel
|
| 8 |
Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer
|
Zhang, Jing
|
|
2017
|
79 |
3 |
p. 479-487
|
artikel
|
| 9 |
Effect of alectinib on cardiac electrophysiology: results from intensive electrocardiogram monitoring from the pivotal phase II NP28761 and NP28673 studies
|
Morcos, Peter N.
|
|
2017
|
79 |
3 |
p. 559-568
|
artikel
|
| 10 |
Effect of food on the bioavailability of palbociclib
|
Ruiz-Garcia, Ana
|
|
2017
|
79 |
3 |
p. 527-533
|
artikel
|
| 11 |
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial
|
Koike, Junichi
|
|
2017
|
79 |
3 |
p. 519-525
|
artikel
|
| 12 |
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer
|
Imai, Hisao
|
|
2017
|
79 |
3 |
p. 497-505
|
artikel
|
| 13 |
Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats
|
Mas-Fuster, María Isabel
|
|
2017
|
79 |
3 |
p. 621-627
|
artikel
|
| 14 |
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis
|
Doi, Toshihiko
|
|
2017
|
79 |
3 |
p. 569-578
|
artikel
|
| 15 |
Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients
|
Wang, Zhan
|
|
2017
|
79 |
3 |
p. 535-543
|
artikel
|
| 16 |
Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab
|
Kuramochi, Hidekazu
|
|
2017
|
79 |
3 |
p. 579-585
|
artikel
|
| 17 |
Phase I study of pazopanib plus TH-302 in advanced solid tumors
|
Riedel, Richard F.
|
|
2017
|
79 |
3 |
p. 611-619
|
artikel
|
| 18 |
Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer
|
Shimizu, Toshio
|
|
2017
|
79 |
3 |
p. 489-495
|
artikel
|
| 19 |
Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mutation carriers with advanced solid tumors or in subjects with high grade serous ovarian, primary peritoneal or fallopian tube cancer
|
Mittapalli, Rajendar K.
|
|
2017
|
79 |
3 |
p. 587-594
|
artikel
|
| 20 |
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy
|
Kasuga, Akiyoshi
|
|
2017
|
79 |
3 |
p. 595-602
|
artikel
|
| 21 |
Reply to: comment on “Meta-analysis of GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer”
|
Kong, Xiangzhen
|
|
2017
|
79 |
3 |
p. 635
|
artikel
|
Tijdschrift beschrijving